ES2163634T3 - Benzopiranos y composiciones farmaceuticas que les contienen. - Google Patents

Benzopiranos y composiciones farmaceuticas que les contienen.

Info

Publication number
ES2163634T3
ES2163634T3 ES96917431T ES96917431T ES2163634T3 ES 2163634 T3 ES2163634 T3 ES 2163634T3 ES 96917431 T ES96917431 T ES 96917431T ES 96917431 T ES96917431 T ES 96917431T ES 2163634 T3 ES2163634 T3 ES 2163634T3
Authority
ES
Spain
Prior art keywords
benzopirans
contain
pharmaceutical compositions
rocesos
benzopiranos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96917431T
Other languages
English (en)
Inventor
Paul W Manley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2163634(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2163634T3 publication Critical patent/ES2163634T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION PROPORCIONA NUEVOS 2,2 UIL) O TRANS 3 HIDROXI 1 BENZOPIRANOS; Y N ROCESOS PARA SU PRODUCCION; Y SUS USOS COMO COMPUESTOS FARMACEUTICOS, POR EJEMPLO, COMO MOLECULAS DE APERTURA DE CANALES DE K SUP,+}, BRONCODILATADORES Y AGENTES PARA LA SUPRESION DE LA HIPERREACTIVIDAD DE LAS VIAS AEREAS, POR EJEMPLO PARA SU USO EN EL TRATAMIENTO DEL ASMA.
ES96917431T 1995-05-24 1996-05-24 Benzopiranos y composiciones farmaceuticas que les contienen. Expired - Lifetime ES2163634T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds

Publications (1)

Publication Number Publication Date
ES2163634T3 true ES2163634T3 (es) 2002-02-01

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96917431T Expired - Lifetime ES2163634T3 (es) 1995-05-24 1996-05-24 Benzopiranos y composiciones farmaceuticas que les contienen.

Country Status (31)

Country Link
US (1) US5905156A (es)
EP (1) EP0828733B1 (es)
JP (1) JPH11505820A (es)
KR (1) KR100437981B1 (es)
CN (1) CN1077888C (es)
AR (1) AR004489A1 (es)
AT (1) ATE205204T1 (es)
AU (1) AU703276B2 (es)
BR (1) BR9609048A (es)
CA (1) CA2217821C (es)
CO (1) CO4700520A1 (es)
CZ (1) CZ294474B6 (es)
DE (1) DE69615019T2 (es)
DK (1) DK0828733T3 (es)
ES (1) ES2163634T3 (es)
FI (1) FI973992A (es)
GB (1) GB9510477D0 (es)
HK (1) HK1014137A1 (es)
HU (1) HU222772B1 (es)
IL (1) IL118382A (es)
MY (1) MY114924A (es)
NO (1) NO314846B1 (es)
NZ (1) NZ309765A (es)
PL (1) PL184144B1 (es)
PT (1) PT828733E (es)
RU (1) RU2160735C2 (es)
SK (1) SK283215B6 (es)
TR (1) TR199701417T1 (es)
TW (1) TW421646B (es)
WO (1) WO1996037490A1 (es)
ZA (1) ZA964209B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) * 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
US7098340B2 (en) 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
CA2999769A1 (en) 2015-09-28 2017-04-06 Genentech, Inc. Therapeutic compounds and methods of use thereof
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
JP2020511511A (ja) * 2017-03-24 2020-04-16 ジェネンテック， インコーポレイテッド ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (es) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
WO1996037490A1 (en) 1996-11-28
DE69615019T2 (de) 2002-06-06
NO975365D0 (no) 1997-11-21
MX9709004A (es) 1998-03-31
TR199701417T1 (xx) 1998-02-21
FI973992A (fi) 1997-12-09
AR004489A1 (es) 1998-12-16
AU6000896A (en) 1996-12-11
FI973992A0 (fi) 1997-10-17
AU703276B2 (en) 1999-03-25
ZA964209B (en) 1997-11-24
JPH11505820A (ja) 1999-05-25
HK1014137A1 (en) 1999-09-24
MY114924A (en) 2003-02-28
ATE205204T1 (de) 2001-09-15
EP0828733A1 (en) 1998-03-18
HUP9801751A3 (en) 1999-08-30
KR19990021925A (ko) 1999-03-25
CA2217821A1 (en) 1996-11-28
NO314846B1 (no) 2003-06-02
TW421646B (en) 2001-02-11
CZ294474B6 (cs) 2005-01-12
PT828733E (pt) 2002-02-28
EP0828733B1 (en) 2001-09-05
PL184144B1 (pl) 2002-09-30
RU2160735C2 (ru) 2000-12-20
SK157797A3 (en) 1998-05-06
CN1077888C (zh) 2002-01-16
HU222772B1 (hu) 2003-10-28
US5905156A (en) 1999-05-18
CO4700520A1 (es) 1998-12-29
BR9609048A (pt) 1999-02-23
KR100437981B1 (ko) 2004-07-16
HUP9801751A2 (hu) 1999-06-28
CA2217821C (en) 2008-05-06
CN1185153A (zh) 1998-06-17
GB9510477D0 (en) 1995-07-19
SK283215B6 (sk) 2003-03-04
IL118382A0 (en) 1996-09-12
IL118382A (en) 2000-01-31
CZ368897A3 (cs) 1998-02-18
NO975365L (no) 1998-01-15
DE69615019D1 (de) 2001-10-11
DK0828733T3 (da) 2001-12-17
NZ309765A (en) 2000-01-28
PL324042A1 (en) 1998-05-11

Similar Documents

Publication Publication Date Title
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
DK1465626T3 (da) Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
DE69430611T2 (de) Phosphonooxymethyl oder Methylthiomethylether von Taxanderivaten als Antitumormittel
GT199900147A (es) 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
BR9900320A (pt) Composição antimicrobiana
ES2165441T3 (es) Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos.
GT199900131A (es) Derivados del acido hidroxi-pipecolato hidroxamico.
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
ES2110015T3 (es) Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
ES2163634T3 (es) Benzopiranos y composiciones farmaceuticas que les contienen.
ES2158496T3 (es) Mezclas aislables a partir de granos de eugenia jambolana lamarck, su preparacion y la utilizacion de estas mezclas y de algunos de sus constituyentes como medicamentos.
ECSP003707A (es) Diazepanes
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
DE69801661D1 (de) Zusammensetzungen welche ein ace-hemmer und ein aldosereductasehemmer enthalten
ES2111175T3 (es) Piperazinas 1,4-disustituidas utiles en el tratamiento del asma y de inflamaciones de las vias respiratorias.
DE69010294T2 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
MX9401295A (es) Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen.
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 828733

Country of ref document: ES